Proceedings of the 52nd Hawaii International Conference on System Sciences | 2019

The Value of Patient-Reported Outcome (PRO) Data in Digital Healthcare:
Using the How-R-you App as a PRO Instrument
Sune Dueholm Müller
Aarhus University
sdm@processinnovation.dk

Morten Mathiasen
Business Academy Aarhus
mmat@eaaa.dk

Abstract
This paper evaluates the value of using a mobile
digital technology for the purpose of collecting PatientReported Outcome (PRO) data. We compare the use of
a paper-based questionnaire and a mobile application
as two different PRO instruments. Based on analysis, we
conclude that use of the mobile application allows for a
more nuanced picture of patients' health to be
established. Implications for diagnosis and medical
treatment are discussed along with the need for future
research.

1. Introduction
A recent study by the OECD concluded that health
spending has outpaced economic growth in member
countries for the past 20 years, and that the rising
healthcare costs are unsustainable without reform
(http://www.oecd.org/health/healthcarecostsunsustaina
bleinadvancedeconomieswithoutreform.htm).
Innovation of healthcare services is needed if the
level of quality in healthcare is to be maintained [15].
This innovation is in part driven by emerging digital
technologies, e.g. mobile technologies. Concurrently,
public sector strategies like the one in Denmark call for
patients playing a larger role in taking responsibility for
their own health and medical treatment. Thus, the
Danish Ministry of Health has defined 8 goals for the
provision of national healthcare services [23] in
collaboration with Local Government Denmark and
Danish Regions. Increased patient involvement is
among these goals. Meanwhile, patient-centered
healthcare requires active engagement of patients [19].
In executing the strategy, use of digital technology is
one of the means by which to increase involvement and
patient empowerment. However, to ensure that the
technology contributes to value creation, designers and
developers of digital technology need to understand and
consider the interests and needs of both patients and
healthcare professionals. Our current knowledge is,
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however, limited and needs to be expanded through
research.
Technology has the potential to provide both
healthcare professionals and patients with information
in support of diagnosis and treatment. Doctors need
accurate information to provide effective and costefficient healthcare. Patients—especially with chronic
diseases—need information in order to help themselves
and self-manage their medical conditions. In many
instances, both parties have incomplete information
about patients' health and how their disease progresses
[8]. In the case of patients with chronic diseases who
need long-term healthcare, being able to continually
monitor the patients and follow any developments is
important from the perspective of doctors. Today,
doctors rely to a large extent on test results (from
periodic blood tests, scans etc.) and dialogue with
patients. In connection with check-ups, patients are
asked to account for not only their well-being and state
of health right now, but also how they have been since
their last check-up, e.g. whether they have experienced
any pain and discomfort, and whether their disease has
impacted their daily lives. The reliability of the data—
or information—provided by the patients is low due to
their difficulties in recalling the details of everyday life
with any accuracy [20].
The question is whether doctors can secure more
reliable information about patients' health, and how data
can be collected to that end by means of technology both
automatically and manually. Data can be collected
automatically by for example tracking patients' vital
signs and physical movements through sensor
technology. In addition, patients can be encouraged to
manually report observations of a more subjective
nature regarding their health by making it convenient,
for example through mobile applications. This leads us
to our research question: To what extent can digital PRO
instruments be used to establish a more accurate picture
of patients' health? We address this question in the
context of a research project that investigates the
relationships between pain, sleep, and disease activity in
an attempt to identify causes of reduced physical
activities and pain among children and adolescents
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diagnosed with arthritis. We focus in particular on the
value from the perspective of doctors of using a mobile
application for collecting Patient-Reported Outcome
(PRO) data. To that end, we compare it to a currently
used PRO instrument—a paper-based questionnaire. In
other words, we evaluate the efficacy of a digital PRO
instrument as compared to conventional, paper-based
methods of patient data collection. Based on our
analysis, we conclude that the app provides more
nuanced if not more accurate information, which opens
for new healthcare possibilities and challenges.
The paper is structured as follows. First, we account
for state-of-the-art knowledge of digital healthcare with
a specific focus on mHealth and technology support for
PRO data collection. Second, we describe our research
approach, including the use of an app that has been
developed and tested as part of this study. Third, we
present our findings, comparing questionnaire and app
data through statistical analyses. Fourth, we discuss the
results in relation to extant literature, stressing the
contribution to mHealth research and the value of app
technology for PRO data collection.

2. Background literature
In this section, we account for extant research within
mHealth, focusing in particular on digital technologies
as instruments for collecting and analyzing PRO data.
According to the World Health Organization there is
no single, agreed-upon definition of mHealth. In their
global survey of eHealth, mHealth (mHealth is a
component of eHealth) is defined as "medical and public
health practice supported by mobile devices, such as
mobile phones, patient monitoring devices, personal
digital assistants (PDAs), and other wireless devices"
[28:6]. This is mirrored in the academic literature where
mHealth is broadly defined as health service delivery
over a mobile or wireless platform: "mHealth is all
about delivering health services and information over a
mobile platform" [17:671]. mHealth is closely related to
digital health. Digital health is the use of digital
technologies for the purpose of facilitating patients’
participation in the healthcare delivery process "to
monitor and improve the wellbeing and health of
patients and to empower patients in the management of
their health and that of their families" [9:246].
Mobile, digital technologies like smartphones drive
development of innovative healthcare solutions due to
their unique characteristics, e.g. mobility, accessibility,
and the ability to collect and transmit data [11]. The
potential for mHealth applications is enormous and
includes continuous surveillance of vital signs and
physiological well-being, as well as access to virtual
care services, drug information, personal electronic

medical records, and a wealth of educational resources
[14]. This is attracting the interest of practitioners and
researchers alike, which is reflected in an increasing use
of apps within the healthcare sector [4].
Among healthcare apps are those that are being used
for collecting data from patients also known as PatientReported Outcome (PRO) data. According to the U.S.
Food and Drug Administration (FDA), "a patient
reported outcome (PRO) is a direct response from the
patient regarding his/her health condition, without a
healthcare provider or caregiver interpretation"
(https://www.fda.gov/ForPatients/PatientEngagement/d
efault.htm#_PRO__), and PRO instruments like apps
are important tools in directly measuring how the patient
feels and functions. These apps and mHealth in general
are interesting in a health economics perspective,
because "a small number of patients, mostly the
chronically sick, are disproportionately costly in any
health-care system. M-health offers a continuous, longterm means of monitoring them, with the potential to
improve the way conditions such as cardiovascular
disease, epilepsy, asthma and diabetes are managed"
[24]. Chronic non-communicable diseases account for a
greater part of "the global disease burden" than that of
"communicable diseases, maternal and perinatal
conditions, nutritional causes and injuries put together
and are expected to increase by 2020" [19:948]. Thus,
mHealth has the potential to improve not only the
interaction and dialogue between healthcare
professional and patients but also the cost and quality of
treatment [7].
Doctor-patient consultations can be conducted more
efficiently if less time is spent on administration (e.g.,
accessing and inputting data in various health
information systems) and more time in actual physical
meetings between patients and doctors [26].
Paradoxically, doctors fear that new technology will
increase rather than decrease their administrative
burdens, and that their introduction will necessitate
time-consuming training and work practice adaptations
[21, 26]. Nevertheless, mHealth introduces a paradigm
shift in the sense that mobile technologies stimulate
innovation and reconceptualization of medical care.
Work processes and routines are being rethought from
the perspective of how best to accomplish the main
objective of providing unsurpassed medical treatment
regardless of how it has been accomplished in the past.
The envisioned application areas are numerous. Apps
could, for example, be used for data collection, patient
monitoring, clinical decision-making, and information
management [25].
According to Gallagher et al. (2015), patientcenteredness is key to effective treatment of chronic
diseases, which entails involving patients more directly
in the treatment process. Regularly registering patient
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data improves the quality of diagnoses and treatment,
partly because healthcare professionals are able to adapt
plans based on PRO data [6]. PRO data opens up new
possibilities, and studies have shown the value of
utilizing such data with regard to making early
diagnoses and freeing up resources [10]. Turning
patients into active participants increases treatment
quality from a patient satisfaction perspective [21].
Furthermore, greater involvement contributes positively
to patient compliance, which can be defined as "the
extent to which a person's behavior—taking medication,
following a diet, and/or executing lifestyle changes,
corresponds with agreed recommendations from a
health care provider" [27:136].
Despite its potential, there are also valid concerns
regarding patient involvement. Among other things, the
quality of PRO data is limited by patients' abilities (or
lack thereof) to remember details about their conditions,
which is referred to as recall bias: “A potential for recall
bias exists whenever historical self-report information is
elicited from respondents” [20:167]. In addition, studies
show that motivating patients to use health apps is
challenging despite the potential of improving their
daily lives. Another challenge is establishing the clinical
value of such PRO instruments, i.e. determining
whether they improve not only doctors' work practices
but more importantly patients' health. Consequently,
more research on the value and limitations of digital
technology enabled PRO instruments is needed [11].
LoPresti et al. (2015) have examined state-of-the-art
research and clinical trials involving mHealth
applications worldwide—most of which take place in
the setting of chronic diseases—and conclude that
"evidence in support of this technology is unclear from
the trials included in this study … Further research
should focus on establishing the effectiveness of
particular mHealth applications and comparing the
effectiveness of these new approaches with that of
existing methods" [13:17, 24]. Our research contributes
to filling that knowledge gap by investigating the extent
to which digital technology can be used to establish a
more accurate picture of patients' health.

3. Research design
In this section, we describe the research background,
the case setting, and the instruments that were used for
PRO data collection as part of the study. The following
subsections will provide detailed descriptions of the app
that was developed as part of the research project as well
as our approach to data collection and analysis.
This paper reports on the research collaboration
between Department of Pediatrics and Adolescent
Medicine at Aarhus University Hospital, Business

Academy Aarhus, and Aarhus University. In 2016, a
group of doctors at the Department of Pediatrics and
Adolescent Medicine initiated a project entitled "Pain,
sleep and disturbed circadian rhythm in Juvenile
Idiopathic Arthritis" for the purpose of identifying
pathological mechanisms behind reduced physical
activity and children's pain. The doctors enlisted the
help of Business Academy Aarhus to develop the HowR-you app (see below) to empower patients to keep
track of their daily symptoms and share the information
with the doctors. The app is envisioned as a supplement
to and potentially a substitute for more traditional means
of collecting data about patients' health.
The Department of Pediatrics and Adolescent
Medicine at Aarhus University Hospital is responsible
for both surgical and medical healthcare services to
children and adolescents in the ages from 0 to 18 years,
including pediatric rheumatology. Diagnosing and
treating children and adolescents with arthritis is a
multidisciplinary teamwork involving doctors, nurses,
psychologists, and physiotherapists—all trained and
experienced in pediatric rheumatology. The main goal
is to detect and aggressively treat arthritis in order to
preserve normal joint function and growth.
Despite new medical treatment modalities, this
group of patients experience reduced quality of life with
pain, decreased physical activity, and sleep disturbances
as major contributors to morbidity [12, 18]. Patients
receive routine check-ups in an outpatient clinic
between 2 and 6 times a year depending on individual
needs. In case of acute arthritis flare, an extra check-up
is scheduled and the patient is closely monitored until
the disease is under control. Such flares can be detected
in patients as painful or swollen joints, but in some cases
the symptoms are not manifest. However, a decrease in
physical activity and general well-being can be
indicative of an arthritis flare. Flares are evaluated by
physical examination of all joints, eyes, skin, and
mucosa. Biochemistry and imaging can assist the
identification of disease activity. Early detection of a
flare as well as monitoring disease related symptoms
such as chronic pain, sleep disturbances, and decreased
physical activity is important in the care of arthritis
patients. Doctors rely on PRO data in diagnosing and
monitoring the disease. It can, however, be difficult for
children and adolescents to recall specific symptoms
and accurately report changes in their state of health
over time.
With regard to information about patients' health, the
doctors depend in part on an internationally recognized
questionnaire—Juvenile Arthritis Multidimensional
Assessment Report (JAMAR) [3]. JAMAR is a
parent/patient-reported outcome measure that is used in
assessing patients' physical and mental well-being,
including how pain is experienced and influences their
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mood and behavior. It also contains disease and
medication specific questions related to arthritis
treatment. The questionnaire is intended to be
completed prior to a scheduled meeting with the doctor.
The answers rely on recalled experiences of disease
symptoms during either the last week or last month.
The app was introduced to counter recall bias and to
give the children and their parents a tool for continually
monitoring their overall state of health in contrast to
only assessing it at fixed points in time, i.e. before a
check-up. The app serves as a means of developing a
multidimensional understanding of pain and the effects
of pain on everyday life for children with arthritis. To
that end, we designed the questions on the basis of
recommendations from the International Association for
the Study of Pain, and included the following "core
outcome domains and measures that should be
considered in clinical trials of treatments for acute and
chronic pain in children and adolescents" [16:771]: pain
intensity, physical functioning, emotional functioning,
and role functioning. In order to automatically monitor
physical activity and sleep (physical functioning) we
included the GENEActiv device (see below).

3.1. The How-R-you app
The idea behind the How-R-you app came from the
doctors who were concerned about the low quality of
PRO data when paper-based questionnaires are used for
data collection purposes. The reliability and validity of
such data are questionable because patients report on
their health and well-being at fixed points in time rather
than on a continuous basis, and they furthermore have
to rely on their ability to recall past behaviors and health
conditions. The app is envisioned as a substitute for the
paper-based questionnaires and as a solution to the data
quality problems.
The app is available through the Apple App Store
and Google Play. It can also be downloaded here:
http://how-r-you.online/en/
The app has been developed in an iterative process
involving patients, doctors, UX designers, and
programmers. Through requirements elicitation, it
became evident that patients want an easy-to-use tool
that allows for daily health registrations and which
provides an overview of their health history.
Additionally, they asked for a free-form text field that
allows them to write daily notes in a diary-style form to
help them monitor their chronic disease.
How-R-you allows for convenient data collection
from patients by means of, e.g., smartphones and tablets.
The app contains modularized and configurable health
related questions. It also includes a diary and provides
an overview of historical data through graphs (see

Figure 2) and tables. The app also integrates with the
GENEActiv accelerometer and collects sensor data.
GENEActiv is a wrist-worn actigraphy device that is
used for temperature, light, and activity monitoring. The
sensor data can be analyzed in order to show the
patient's level of physical activity and sleep pattern.
(https://www.activinsights.com/products/geneactiv/).
All registered data is sent in real time to a central
database from which doctors and patients can access the
data as needed. The data is password protected and
encrypted to ensure that only authorized personnel have
access to the data.
The app is designed with user-friendliness in mind.
As a substitute for paper-based questionnaires, it is an
interactive tool that requires only a few activity steps on
the part of users. Both the home screen of the app and
the modularized questions are configurable to serve the
individual needs of doctors and patients. Due to the
feedback from patients and doctors during the design
process, the number of questions, their wording, and
response formats (e.g., numerical input, multiple choice,
and slider scales) are tailorable to individual needs.
In this study, the app is configured to include two
modules, "Pain" and "Pain relief", which are accessible
through the dashboard on the home screen depending on
user settings (see Figure 1).

Figure 1. How-R-you home screen
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In addition, it provides an overview of the patient's
activity as monitored through the GENEActiv
actigraphy device (see Figure 2).

Figure 3. How-R-you "Pain" module

3.2. Data collection

Figure 2. GENEActiv activity graph
The "Pain" module (see Figure 3) contains questions
about pain intensity, where it is located, as well as the
patient's level of physical activity, mood, and ability to
participate in everyday activities. "Pain relief" focuses
on methods and effects of relieving the pain, e.g. what
the patient has done to alleviate the pain and what the
outcome has been. The response format is an 0-10 slider
scale (also known as Visual Analog Scale). The "Pain"
questions are documented in the appendix.

As mentioned in the introduction, this paper is based
on a research project that investigates the relationships
between pain, sleep, and disease activity in an attempt
to identify causes of reduced physical activities and pain
among children and adolescents diagnosed with
arthritis. The long-term goal is to identify effective
methods of treatment and pain relief and as a
consequence improve the quality of life among patients.
98 patients are included in the study "Pain, sleep and
disturbed circadian rhythm in Juvenile Idiopathic
Arthritis". It was determined that 85 would be sufficient
to cover patients aged 6-16 years diagnosed with all 7
types of arthritis. The study has been approved by the
regional committee on health research ethics and
complies with applicable data protection laws. Informed
consent was obtained from all participants and their
guardians. The patients received instructions by a
medical student and researcher.
Each patient participates over a three-month period,
it includes two outpatient check-ups—one at inclusion
and one by the end of the study—the purpose of which
is routine assessments of disease activity. The patients
were required to wear the GENEActiv device for the
purpose of monitoring their level of physical activity
and sleep pattern. They were also asked to write sleep
diaries, fill out JAMAR questionnaires, and use the
How-R-you app for one week following each of the two
check-ups.
JAMAR is a paper-based questionnaire. In this
study, the validated Danish translation of JAMAR was
imported into REDCap, which is "a web application for
building and managing online surveys and databases"
(https://www.project-redcap.org). It was subsequently
e-mailed to the parents of children included in the study.
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They were asked to fill out the JAMAR questionnaire
on the day of the check-up. Furthermore, the patients
were asked to download How-R-you, were provided
with unique login information, and were asked to use the
app daily. They were instructed to answer the app
questions at least once a day for a week while wearing
the GENEActiv device. All patients participated twice
during the study—one week at the beginning of the
research project and one week toward the end. The
GENEActiv device served to identify each patient's
circadian rhythm and ascertain whether this rhythm was
affected by the patient's experienced pain. In evaluating
and choosing between many different actigraphy
devices, we opted for many sensory registrations per
minute over a one-week period rather than fewer
registrations over a longer period of time. Data from
both weeks are included in the dataset. Each patient was
assigned a unique ID in REDCap and stored along with
How-R-you credentials.
All app activities and patient registrations (both in
JAMAR and How-R-you) were recorded and
timestamped. All data have been exported from the
database for the purpose of data analysis using the Stata
statistics software package (https://www.stata.com).
3.2.1. Ethics. In relation to our data collection, we
discussed at length the potential risk and ethical concern
of sickening the patients. By asking patients to daily
monitor their health and respond to questions in the app,
there is a possibility of constantly reminding the patients
that they suffer from a chronic disease beyond the
disease's normal cognitive saliency, which might
influence their mood and mental well-being—and thus
their state of health—in a negative way. For most
patients the disease is, however, already a conscious part
of their everyday lives. Furthermore, there is no wellestablished pain assessment method. Previous studies
have confronted patients with variable number of
questions about when patients experience pain [2]. For
the purpose of this study we decided to monitor patients'
health continuously and ask them to answer questions at
least once a day. We therefore assess the risk as very
low to the point where it is a concern that needs to be
monitored as our ongoing research efforts move
forward.

3.3. Data analysis
The analyses are based on cross sectional time-series
data (panel data) since the data has been collected over
two different time periods through, on the one hand, the
JAMAR questionnaire and, on the other hand, the HowR-you app (December 2016 – November 2017).

Because of the nature of the data (cross sectional
time-series data), the analyses are based on panel data
models describing individual behavior over time and
across individuals. There are several estimation
techniques for analyzing panel data models, but at a
general level there is a distinction between pooled
Ordinary Least Squares (OLS) models, fixed effects
models, and random effects models. We rely on both
fixed and random effects models depending on the
particular regression model, since Hausman
specification tests have shown them to be the most
appropriate and effective estimation techniques (for
more about fixed and random effects, see [5]).
A Hausman specification test has been conducted for
each regression model to determine if the specific
regression model should be estimated using either fixed
or random effects. Fixed effects are used if the p-value
of the Hausman test falls below 0.05 (significance
level), and random effects are used if the p-value
exceeds 0.05 [1]. All analyses are based on the
recognized 0.05 significance level (p <0.05), but since
the number of respondents are relatively low, relations
at an 0.1 significance level (p <0.1) are highlighted as
well. When p < 0,001, it is also emphasized. Each
regression model displays the bivariate relationship
between the study’s independent (pain intensity) and
dependent variables (level of physical activity, mood,
and participation in activities) and is analyzed using
Stata.
In the appendix, we have listed the questions that are
compared across JAMAR and How-R-you. Despite
differences in wording, the same questions (variables)
are included in both the questionnaire and the app.

4. Analysis
In this section, we compare questionnaire (JAMAR)
and app (How-R-you) responses through descriptive
statistics and regression analysis. In the end, we
conclude that the app as a PRO instrument provides for
a more nuanced picture of patients' health.
If we compare JAMAR and How-R-you responses,
we see some interesting results. In terms of descriptive
statistics, 61% of all respondents have answered both
JAMAR and How-R-you questions. 93 respondents
have filled out the questionnaire and 66 have used the
app.
The average registered pain intensity is higher when
looking across questionnaire responses compared to the
app data. However, the maximum registered pain is
higher in the app than in the questionnaire. This is
consistent with extant research, which shows that
patients respond to questions regarding pain based on
the maximum pain intensity experienced.
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Table 1 displays a comparison of patients' responses
to questions regarding average pain intensity, level of
physical activity, mood, and participation in activities in
both the JAMAR questionnaire and the How-R-you app.
Table 1. Comparison of questionnaire and app
responses
Model I
Pain
intensity
-0,588
(0,422)

Model II
Physical activity

Constant

3,150**
(0,672)

n
R2

App

Model
III
Mood
-0,633
(0,386)

Model
IIII
Activity
-1,582**
(0,461)

-,060(0,432)

2,273**
(0,613)

4,333**
(0,732)

129

127

128

128

0,015

0,035

0,021

0,086

0,576* (0,271)

*p < 0,05; **p < 0,001. Reference category for the app is the
questionnaire. The dependent variables are scaled from 0-10, where
10 indicates a high impact of pain on level of physical activity, mood,
and participation in activities, and conversely 0 indicates a low impact.

The respondents indicate that the experienced pain
has influenced their level of physical activity (in terms
of, e.g., running, jumping, writing, and cutting with
scissors)—less so when asked in the questionnaire (0,52
on average) than in the app (1,09 on average). In other
words, when asked daily about their health and wellbeing, the patients indicate being more impeded by pain
than when asked to look back at the period since their
last consultation. This might be a sign of a coping
mechanism or simply that patients do not remember the
pain influencing their level of activity.
When it comes to the experienced pain affecting
their mood, the app score (1,01 on average) is lower than
that of the questionnaire (1,64 on average). Meanwhile,
the maximum registered value in the app (10) is
identical to that of the questionnaire (10).
Similarly, looking at the extent to which the
experienced pain has prevented the patients from
participating in their usual activities (e.g., going to
school, playing with friends, and participating in sports),
the app score (1,17 on average) is lower than that of the
questionnaire (2,75 on average). As with the impact of
pain on their mood, the maximum registered value in the
app (10) is identical to that of the questionnaire (10).
The regression analyses show that there is no
significant difference between the registered pain
intensity and mood across app and questionnaire.
Looking at the beta coefficients, it can be inferred that
the pain intensity and mood fall by 0.59 (-0,59) and 0,63
(-0,63) points respectively (NB: The dependent variable
is scaled from 0 to 10) when transitioning from filling
out the questionnaire to using the app. Opposite results
are seen with regard to the level of physical activity and

participation in activities in the sense that there are
significant differences across app and questionnaire.
The beta coefficients show that the level of physical
activity increases by 0.58 points and participation in
activities falls by 1,58 (-1,58) points respectively when
going from the questionnaire to the app. The results with
regard to pain intensity, mood, and participation in
activities are consistent with expectations of lower
values registered in the app compared to the
questionnaire.
Table 2 displays how the patients' pain intensity
affects their level of physical activity, mood, and
participation in activities.
Table 2. Effect of pain intensity on level of
physical activity, mood, and participation in
activities
Model I
Physical
activity (RE)
0,303**
(0,054)

Model II
Mood (RE)
0,435**
(0,074)

Model III
Activity
(RE)
0,631**
(0,088)

Constant

0,130 (0,187)

0,328
(0,248)

0,503†
(0,297)

n

127

128

128

Rho

0,357

0,136

0,196

Pain intensity

†p < 0,1; **p < 0,001. Reference category for the app is the
questionnaire. The dependent variables are scaled from 0-10, where
10 indicates a high impact of pain on level of physical activity, mood,
and participation in activities, and conversely 0 indicates a low impact.

The regression analyses show significant
relationships between pain intensity, on the one side,
and physical activity, mood, and participation in
activities on the other side. The beta coefficient
indicates that the impact of pain on level of physical
activity rises 0,30 when the pain increases 1 point in
intensity. For mood and participation in activities, the
effects are 0,43 and 0,63, respectively.

5. Discussion
This paper is the first step in addressing the need for
more research that investigates the clinical value of PRO
instruments (Lee et al. 2015) for the purpose of
improving accuracy in patient data collection. In this
paper, we look at the value from the perspective of
doctors in evaluating whether the How-R-you app
provides them with more valid and reliable information
about patients' health compared to the periodic survey
instrument JAMAR. Such information has the potential
to improve medical work practices in support of
diagnosis and treatment by enabling the doctors to make
more informed and timely decisions based on more
nuanced if not more accurate pictures of patients' health.
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The analyses show that even patients who are
severely tormented by pain experience days with little
or no pain. The app data allows for more detailed
information about patients' health in the sense that the
actual frequency of days with pain can be visualized
together with the impact of pain on everyday life. As a
consequence, doctors and patients have the means to
recognize symptom patterns, indicating disease flare or
the need to adjust pain treatment. Proper detection of a
flare by comparing the associated pain with chronic pain
is crucial for selecting the correct treatment. Early
detection of a flare will signal a need for more intensive
arthritis treatment. If the pain is chronic in nature, it is
helpful to reflect on "good" as well as "bad" days, i.e.
days with less versus more pain, because it may inform
an effective treatment strategy. Daily app registrations
of pain and how it affects patients in their daily lives
provide doctors with a more nuanced picture of patients'
health. In the future, this nuanced picture can be used to
improve treatment and thereby the health of this patient
group.
The well-known relationship between high pain
intensity, low mood, decreased physical activity, and
diminished social functioning [22] is captured by both
JAMAR and How-R-you. However, some differences in
patients' responses to questionnaire and app questions
are significant, namely with regard to the level of
physical activity and participation in activities, whereas
others are not, specifically pain intensity and mood. This
supports our assumption that patients answer JAMAR
questions based on the most intensive pain they recall
having experienced during the previous period.
However, because the patients have used the app
differently (some have used it several times a day and
others have not used it every day despite the doctors'
instructions), it is not possible to make any conclusions
about pain variation over time across patients.
Meanwhile, looking at individual patients' responses,
for example with regard to pain intensity, substantial
differences are clearly discernable, which again
confirms our expectation that using the app supports a
more nuanced picture of patients' health. This more
nuanced picture of patients' health makes it possible to
better evaluate whether certain pain management
interventions (e.g., music therapy and meditation) have
the desired effects. Moreover, with regard to the choice
of treatment strategies (for example during "patientcentered talks"), the app data can be used because they
allow for a discussion of day-to-day activities, and how
they relate to experienced pain, medication, and much
more.
Though we expected that the app facilitates a more
accurate picture of patients' health, because they are
asked to register data daily regarding their current health
conditions compared to more retrospective evaluations

over a longer period of time when they respond to the
questionnaire, our analyses are inconclusive due to the
fact that some of the identified differences are
significant while others are not. However, there are clear
advantages of using the app for collecting PRO data, not
least the ability to establish a link between pain
experienced now or very recently, patients' daily
activities, and their well-being. In JAMAR, the patients
answer many questions regarding their physical
conditions that are not necessarily relevant to every
child or adolescent. Moreover, because the answers
relate to past experiences—sometimes weeks in the
past—it is much more difficult to assess the impact of
pain.
Although some differences across How-R-you and
JAMAR are not significant, it is important to note the
relatively small sample size, which may account for the
non-significant differences in questionnaire and app
responses. Looking at the individual responses, there are
substantial differences in each patient's answers across
JAMAR and How-R-you which confirms our
expectation that the app facilitates a more nuanced—if
not more accurate—picture of patients' health, and how
pain influences their daily lives.
In summary, our study shows that digital PRO
instruments like How-R-you can provide doctors with
valid and reliable information in support of planning,
monitoring, and improving treatment. In addition, such
instruments may potentially increase patient satisfaction
and compliance through their active involvement.
Moreover, the PRO data may improve patient-doctor
communication for the purpose of ensuring effective
treatment strategies. However, since this study adopts
the perspective of doctors, future studies are needed to
investigate these potential values.

5.1 Limitations
In this study, we have investigated the potential
value of using an app for collecting PRO data from the
perspective of doctors. The data collected through the
app helps doctors better diagnose diseases and monitor
patients' health. In the end, because data is not collected
automatically but needs to be registered manually by
patients, it is important that patients are motivated, and
that the app facilitates easy data registration. We are
currently investigating the value perspective of patients.
One of the envisioned benefits of using How-R-you is
that patients have the possibility of monitoring their own
medical conditions and reflecting on questions
regarding their health (How much pain am I
experiencing right now? How does it impact my
physical condition and mental well-being?) in the hope
that it may lead to pattern recognition (When did I
experience it the last time? How did I cope? What was
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the effect?) and an improved ability to self-manage their
disease on a daily basis. An important limitation of our
study is that we do not control for the use of different
technologies for data collection purposes. It is possible
that the use of digital technologies (e.g., How-R-you)
might influence not only data reporting but also the
reported data and therefore the subsequent analysis.
Future studies should consider including control
variables such as computer self-efficacy, level of
experience with digital technology, overall technology
affinity etc.
Meanwhile, anecdotal evidence indicates that
patients primarily use the app, because they want to help
the doctors. Consequently, we need to better understand
what motivates patients, and how they can be
encouraged to take greater part in managing their own
health, for example through technology use. To that end,
we are studying the information needs of patients, and
how digital technology like the app contributes to value
creation from their perspective in order better to
understand how to design and use such technologies.
Our findings will be reported in forthcoming
publications.

6. Conclusion
This paper reports on a study in which we set out to
investigate the extent to which digital technology can be
used to establish a more accurate picture of patients'
health. We have collected PRO data using both a
questionnaire and an app in a project that focuses on
studying the relationships between pain, sleep, and
disease activity among children and adolescents
diagnosed with arthritis. We conclude that the use of
digital technology (i.e., the app) allows for a more
nuanced picture of patients' health to be established, and
we discuss how the more detailed information can be
used by doctors to better care for the patients through
more effective treatment strategies and evaluation. In
addition, we speculate that patients are better equipped
to self-manage their disease. These advantages of using
mobile digital technology have the potential to improve
the health and quality of life of the patients. We will
leave it to future studies to investigate this further.
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Table A2. How-R- you ("Pain") questions

Appendix
1

Table A1 and A2 contain the questions for PRO
data collection across JAMAR and How-R-you.
Table A1. JAMAR questions
1
2

3
4

"How much pain have you had because of the illness over the
past week?" (VAS 0-10; score of 0 = "No pain" and score of 10
= "Extreme pain")
Evaluation of functional ability based on a JAFS (Juvenile
Arthritis Functionality Scale) score; a 15-item questionnaire
evaluating the child’s ability to perform specific tasks during the
past four weeks (each item is scored 0-2 where 0 = "With NO
difficulty", 1 = "With SOME difficulty", and 2 = "With MUCH
difficulty"; total score range is 0-30)
"Consider the past four weeks, have you had any difficulty
carrying out activities that require a lot of energy?" (4-point
Likert-type scale; 0 = "Never" and 3 = "Every day")
"Consider the past four weeks, have you felt sad or depressed?"
(4-point Likert-type scale; 0 = "Never" and 3 = "Every day")

2
3
4

5

6

"Time" (time of day that the registration concerns is
automatically detected but can be changed manually by the
patient)
"How much pain did you experience today?" (Visual Analog
Scale (VAS) 0-10; score of 0 = "No pain" and score of 10 =
"Extreme pain")
"Where does it hurt today?" (multiple choices: head, neck, back,
legs, feet, arms, hands, and no pain)
"Does the pain mean you could not be as physically active as
you would otherwise? (E.g., run, jump, write, cut with scissors)"
(VAS 0-10; 0 = "Not at all" and 10 = "Completely prevented all
activity")
"Has the pain prevented you from doing what you would
otherwise do today? (E.g., school, play with comrades, go to
sports)" (VAS 0-10; 0 = "Not at all" and 10 = "Completely
prevented all activity")
"How much has the pain impacted your mood during the day?"
(VAS 0-10; 0 = "No impact" and 10 = "Extreme impact")
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